Cladribine Active Not Recruiting Phase 4 Trials for Multiple Sclerosis / Relapsing Remitting Multiple Sclerosis (RRMS) Basic Science

IndicationsStatusPurposePhase
Active Not RecruitingBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT03963375Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis